Tissium

Tissium company information, Employees & Contact Information

Explore related pages

Related company profiles:

TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.

Company Details

Employees
143
Founded
-
Address
74, Rue Du Faubourg Saint-Antoine, Paris,ile-De-France 75012,france
Phone
+33 1 76 21 72 28
Email
in****@****ium.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Paris, Ile-de-France
Looking for a particular Tissium employee's phone or email?

Tissium Questions

News

TISSIUM Announces U.S. Commercial Launch of COAPTIUM® Connect and Strategic Governance Evolution - Yahoo Finance

TISSIUM Announces U.S. Commercial Launch of COAPTIUM® Connect and Strategic Governance Evolution Yahoo Finance

TISSIUM selected for the French Tech 120 Program - Yahoo Finance

TISSIUM selected for the French Tech 120 Program Yahoo Finance

TISSIUM Receives FDA De Novo Authorization for COAPTIUM® - GlobeNewswire

TISSIUM Receives FDA De Novo Authorization for COAPTIUM® GlobeNewswire

TISSIUM Selected for the French Tech 120 Program - ACCESS Newswire

TISSIUM Selected for the French Tech 120 Program ACCESS Newswire

TISSIUM Advances Clinical Pipeline in Hernia Repair Following First FDA Authorization - Yahoo Finance

TISSIUM Advances Clinical Pipeline in Hernia Repair Following First FDA Authorization Yahoo Finance

TISSIUM Announces Clinical Results of COAPTIUM® CONNECT System for Atraumatic Sutureless Nerve Repair - GlobeNewswire

TISSIUM Announces Clinical Results of COAPTIUM® CONNECT System for Atraumatic Sutureless Nerve Repair GlobeNewswire

Cathay Health Increases its Stake in TISSIUM with €50M Series D - Cathay Capital

Cathay Health Increases its Stake in TISSIUM with €50M Series D Cathay Capital

TISSIUM wins FDA approval for sutureless nerve repair platform - Medical Device Network

TISSIUM wins FDA approval for sutureless nerve repair platform Medical Device Network

Tissium snags FDA de novo clearance for sutureless nerve repair - Fierce Biotech

Tissium snags FDA de novo clearance for sutureless nerve repair Fierce Biotech

TISSIUM Appoints Romain Attard as Chief Financial Officer - Business Wire

TISSIUM Appoints Romain Attard as Chief Financial Officer Business Wire

MedTech Innovators: Tissium co-founder Maria Pereira on taking tech from bench to bedside - MedTech Dive

MedTech Innovators: Tissium co-founder Maria Pereira on taking tech from bench to bedside MedTech Dive

FDA clears path for Paris startup TISSIUM's tissue reconstruction without sutures, redefining surgical standards - Tech.eu

FDA clears path for Paris startup TISSIUM's tissue reconstruction without sutures, redefining surgical standards Tech.eu

Tissium’s polymer solution set to transform nerve repair after FDA nod - BioWorld MedTech

Tissium’s polymer solution set to transform nerve repair after FDA nod BioWorld MedTech

3D Systems and TISSIUM Receive FDA Approval for First-of-its-Kind Peripheral Nerve Repair Device - 3D Printing Industry

3D Systems and TISSIUM Receive FDA Approval for First-of-its-Kind Peripheral Nerve Repair Device 3D Printing Industry

TISSIUM Raises €50M in Series C Financing to Propel its Platform to Commercial Stage - Cathay Capital

TISSIUM Raises €50M in Series C Financing to Propel its Platform to Commercial Stage Cathay Capital

TISSIUM Selected for the French Tech 120 Program - ACCESS Newswire

TISSIUM Selected for the French Tech 120 Program ACCESS Newswire

TISSIUM Raises €50M in Series D Funding to Finance its Commercial Launch and Platform Extension - Yahoo Finance

TISSIUM Raises €50M in Series D Funding to Finance its Commercial Launch and Platform Extension Yahoo Finance

Behind the Term Sheet: How TISSIUM is creating the future of tissue reconstruction with biomorphic programmable polymers - Cathay Capital

Behind the Term Sheet: How TISSIUM is creating the future of tissue reconstruction with biomorphic programmable polymers Cathay Capital

Top Tissium Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant